SCHEMBL30697976

SCHEMBL30697976

CC1(C)OCC(COC(=O)OCCl)O1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.49
TMEM97 Q5BJF2 2/20 0.38
SIGMAR1 Q99720 2/20 0.38
ALDH1A1 P00352 3/20 0.36
NPSR1 Q6W5P4 1/20 0.35
HTR7 P34969 1/20 0.35
F10 P00742 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
CA1 P00915 1/20 0.32
KCNJ5 P48544 1/20 0.31
KCNJ3 P48549 1/20 0.31
DGAT1 O75907 1/20 0.31
APP P05067 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18395904 0.92 CA2 (0.56) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL6943821 0.92 CA2 (0.56) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL30401615 0.88 CA2 (0.47) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL13651150 0.86 CA2 (0.50) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL4132454 0.86 CA2 (0.50) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL7042446 0.85 CA2 (0.53) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL6941294 0.84 CA2 (0.49) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL10441415 0.84 CA2 (0.51) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL13063460 0.84 CA2 (0.51) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL1922788 0.82 CA2 (0.53) CA2TMEM97SIGMAR1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230364101-A1 DICLOFENAC PRODRUG AND USE OF THE SAME Pumont Biotech Co., Ltd. (TW) 2023-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230364101-A1 DICLOFENAC PRODRUG AND USE OF THE SAME CYP2D6, CYP2C9, CYP2B6 CA2 946/4885TMEM97 3817/4885SIGMAR1 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.